The government's drug funding agency Pharmac is asking for public feedback on its proposal to fund four new medicines for ...

One in nine New Zealand women get breast cancer in their lifetimes, and around 16% of metastatic breast cancers are ...

NCR, there has been a huge surge in the demand for respiratory drugs like Foracort, which has emerged as the top-selling ...

Amid high AQI in Delhi, there's been a surge in the demand for respiratory drugs. Foracort, a respiratory drug, has emerged ...

Global respiratory inhalers market is estimated to be valued at USD 33.11 Bn in 2024 and is expected to reach USD 49.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to ...

Pulmicort (budesonide) is an asthma drug that’s considered safe to use while pregnant. The drug passes into breast milk but is also considered safe to use while breastfeeding. Pulmicort is ...

Drug firm AstraZeneca Pharma India Ltd on Monday (November 18) said it has received import and market permission from the Drugs Controller General of India (DCGI) for its inhalation preparation, ...

Conclusion: Budesonide Clickhaler® and budesonide Turbuhaler® dry powder inhalers demonstrated similar ... and the Turbuhaler® achieve similar drug delivery.